Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
about
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerEstrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells.Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signalingHyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.Inhibition of Ras for cancer treatment: the search continues.Femara and the future: tailoring treatment and combination therapies with Femara.Salirasib in the treatment of pancreatic cancer."Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future?Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.Crosstalk with insulin and dependence on PI3K/Akt/mTOR rather than MAPK pathways in upregulation of basal growth following long-term oestrogen deprivation in three human breast cancer cell lines.Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
P2860
Q26862550-B343A2E7-6FA3-4038-9E2B-90D2E48A67A8Q30433113-25A0C17D-7717-45D4-94D3-208D07008920Q30440238-A5A03583-89A6-4C1C-95AE-B608D507660FQ30441321-F4AB6581-138A-4D90-9EA5-267E8F3A0560Q33604076-5A0F512E-2F9A-4BDD-83EB-9011D4776ED3Q33968076-62135457-BDCC-4F95-A689-142B81638953Q35944601-B5D24CC3-0EFF-4843-AC56-A131F3AD15FDQ36026429-773975AC-80F3-4AAE-AEA6-37CA36570AFDQ37763095-5632481F-AFDC-4C93-9A7C-88EB23CE008EQ37800039-89269539-7B1B-4EEB-A8A1-8519D9BA1666Q39667297-8EA01FF9-F11B-4CFB-97D3-358A93F88847Q42476835-F485CBD5-B689-4271-9274-5BD511196EDFQ46685190-9269F2D1-0F08-4DC9-8DCE-05ABB12578FD
P2860
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@ast
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@en
type
label
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@ast
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@en
prefLabel
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@ast
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@en
P2093
P356
P1476
Farnesylthiosalicylic acid blo ...... naling in breast cancer cells.
@en
P2093
Jiping Wang
Richard J Santen
P2860
P304
P356
10.1002/IJC.21222
P577
2005-12-01T00:00:00Z